IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

Use an existing password
Company dossier

Sun Pharmaceutical

NSE:SUNPHARMA · ISIN INE044A01036

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Sun Pharmaceutical

Filings

Preserved evidence

Primary-source filing timeline

40 recent events
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Conclusion Of The Board Meeting Held Today, I.E., 31 July 2026BSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Voting Results And Scrutinizer Report Of 34Th AGM Held On 31 July 2026BSE · exchange filing · pdf
Source filing
General Updates - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing
Shareholders meeting - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Q1FY27-Investor Call Audio RecordingBSE · conference call · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - Sun Pharmaceutical Industries LimitedNSE · conference call · pdf
Source filing
General Updates - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Unaudited Standalone And Consolidated Financial Results For Q1 Of FY 2026-27BSE · financial results · pdf
Source filing
Outcome of Board Meeting - Sun Pharmaceutical Industries LimitedNSE · financial results · pdf
Source filing
Press Release - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
General Updates - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Update On NidlegyBSE · exchange filing · pdf
Source filing
Press Release - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Press Release - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Archived filing
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - Sun Pharmaceutical Industries LimitedNSE · conference call · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Archived filing
Sun Pharmaceutical Industries Ltd - 524715 - Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026BSE · financial results · pdf
Source filing
Copy of Newspaper Publication - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing
Investor Presentation - Sun Pharmaceutical Industries LimitedNSE · investor presentation · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Archived filing
Business Responsibility and Sustainability Report FY 2025-2026 - Sun Pharmaceutical Industries Limited (SPIL)NSE · business responsibility report · pdf
Source filing
Annual Report FY 2025-2026 - Sun Pharmaceutical Industries LimitedNSE · annual report · pdf
Source filing
Annual Report 2026 - Sun Pharmaceutical Industries Ltd.BSE · annual report · pdf
Archived filing
Shareholders meeting - Sun Pharmaceutical Industries LimitedNSE · annual report · pdf
Archived filing
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Notice Of 34Th Annual General Meeting To Be Held On 31 July 2026 Along With The Annual Report For FY 2025-26BSE · annual report · pdf
Archived filing
Sun Pharmaceutical Industries Ltd - 524715 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing
Sun Pharmaceutical Industries Ltd - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Trading Window - Sun Pharmaceutical Industries LimitedNSE · exchange filing · pdf
Source filing
Sun Pharmaceutical Industries Ltd - 524715 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing